OpenVSafe by OpenVAERS
Search V-safe

2H8-68618-72103

2 vaccinations 1 coded response 11 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
393 / MS
Registered
2021-02-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Dose 1 — Moderna
  2. 2021-02-05
    Registered in v-safe
  3. 2021-02-05
    Dose 2 — Moderna
  4. 2021-02-05
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain, Swelling · Diarrhea
    Adult check-in
  5. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-02-06
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches
    Adult check-in
  8. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  9. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-02-07
    Survey response — 12 months, dose 2
    MedDRA: Gastrointestinal disorder, Nasal congestion, Nausea — Feeling: Fair
    Free text: Gi issues, nausea, stuffy nose
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Moderna
22021-02-05Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-02-06 priority 2/3

Free text

Release 11 — 12 months, dose 2

2022-02-07

Symptoms: Gi issues, nausea, stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGastrointestinal disorder · · ✓
SDNasal congestion · · ✓
SDNausea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release